Cargando…
Identification and Validation of a Hypoxia-Immune-Based Prognostic mRNA Signature for Oral Squamous Cell Carcinoma
BACKGROUND: Oral squamous cell carcinoma (OSCC) is a commonly encountered head and neck malignancy. Increasing evidence shows that there are abnormal immune response and chronic cell hypoxia in the development of OSCC. However, there is a lack of a reliable hypoxia-immune-based gene signature that m...
Autores principales: | Lv, Shaohua, Qian, Zhipeng, Li, Jianhao, Piao, Songlin, Li, Jichen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844353/ https://www.ncbi.nlm.nih.gov/pubmed/35178089 http://dx.doi.org/10.1155/2022/5286251 |
Ejemplares similares
-
A 3-mRNA-based prognostic signature of survival in oral squamous cell carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2019) -
A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma
por: Zhao, Chenguang, et al.
Publicado: (2021) -
Inhibition of autophagy by 3-MA enhances IL-24-induced apoptosis in human oral squamous cell carcinoma cells
por: Li, Jichen, et al.
Publicado: (2015) -
Identification of a prognostic 4-mRNA signature in laryngeal squamous cell carcinoma
por: Zhang, Cheng, et al.
Publicado: (2021) -
Development and validation of a novel hypoxia-related signature for prognostic and immunogenic evaluation in head and neck squamous cell carcinoma
por: Li, Su-Ran, et al.
Publicado: (2022)